美股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

禮來

796.00

+2.990.38%

成交量：78.46萬

成交額：6.23億

市值：7,543.98億

市盈率：64.77

高：798.77

開：789.10

低：787.36

收：793.01

資料載入中...

總覽公司新聞公告

減肥藥邁入“吃藥時代”？禮來口服神藥試驗成功，股價飆漲創25年新高！

海外市場 | 美股繼續調整，禮來口服減肥藥火爆

Ofweek维科网

GLP-1競爭新動向：禮來後來居上？

一週美股牛榜 | 禮來飆升15%；美元樹升10%；德文能源、阿帕契、慧與科技升逾7%

老虎资讯综合

醫藥行業週報：禮來首個小分子口服GLP-1藥物3期臨牀研究成功有望改變減重藥物格局

平安证券股份有...

醫藥行業週報：本週醫藥下跌0.4% 人民時評要求保證藥企藥店利潤空間禮來口服GLP-1治療糖尿病研發成功

上海申银万国证...

諾和諾德、禮來“二王爭霸”，國產GLP-1搶奪新適應症，恆瑞醫藥們不想只做減肥神藥

減重GLP-1製劑將進入每日一次“口服”時代禮來回應：已在準備產能計劃

每日经济新闻

禮來預計年底前向全球監管機構提交新款減肥藥的上市申請

老虎资讯综合

禮來公佈口服降糖藥積極結果，或年底前提交用於體重管理上市申請

大摩：口服減肥藥Orforglipron成股價推動力禮來還能再漲34%

智通财经网

GLP-1減肥藥市場博弈：禮來領航突破、輝瑞折戟沉沙，創新戰如何取勝？

21世纪经济报道

禮來首個小分子口服GLP-1藥物3期臨牀研究成功有望顛覆減重藥物格局

禮來4月17日成交額為91.53億美元

“減肥神藥”進入口服時代，禮來登頂“減肥藥王”？

华尔街见闻

美聯邦法官裁定谷歌非法壟斷部分廣告技術市場；禮來首款GLP-1口服藥報告積極三期試驗結果丨全球科技早參

每日经济新闻

美國股市：三大股指在震盪交投中漲跌互現，投資者評估貿易磋商和利率前景

太平洋醫藥日報：禮來口服GLP-1受體激動劑ORFORGLIPRON三期臨牀成功

太平洋证券股份...

美股異動 | 口服減肥藥Orforglipron三期臨牀數據亮眼禮來(LLY.US)漲逾13%

禮來(LLY)漲超16% 諾和諾德(NVO)跌逾8% Orforglipron研究取得積極結果

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/LLY/news?page=17"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LLY","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LLY\",,,,,undefined,":{"symbol":"LLY","market":"US","secType":"STK","nameCN":"禮來","latestPrice":796,"timestamp":1752509421469,"preClose":793.01,"halted":0,"volume":784641,"delay":0,"floatShares":944999999,"shares":947735651,"eps":12.289877,"marketStatus":"交易中","change":2.99,"latestTime":"07-14 12:10:21 EDT","open":789.1,"high":798.77,"low":787.36,"amount":623392880.5104,"amplitude":0.014388,"askPrice":796.64,"askSize":31,"bidPrice":795.9,"bidSize":103,"shortable":3,"etf":0,"ttmEps":12.289877,"tradingStatus":2,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1752523200000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":102488400000,"exchange":"NYSE","adjPreClose":793.01,"dividendRate":0.006784,"preHourTrading":{"tag":"盘前","latestPrice":790.57,"preClose":793.01,"latestTime":"09:29 EDT","volume":4795,"amount":3786054.8005,"timestamp":1752499798325},"postHourTrading":{"tag":"盘后","latestPrice":791.86,"preClose":793.01,"latestTime":"19:59 EDT","volume":105235,"amount":83448672.5901,"timestamp":1752278370210},"volumeRatio":0.652459,"impliedVol":0.4637,"impliedVolPercentile":0.888},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LLY\",,,,,undefined,":{"symbol":"LLY","floatShares":944999999,"roa":"16.45%","roe":"77.28%","lyrEps":11.758762,"volumeRatio":0.652459,"shares":947735651,"dividePrice":5.4,"high":798.77,"amplitude":0.014388,"preClose":793.01,"low":787.36,"week52Low":677.0912,"pbRate":"47.85","psRate":"15.39","week52High":972.53,"institutionHeld":0.8572,"latestPrice":796,"committee":0.537313,"eps":12.289877,"divideRate":0.006784,"volume":784641,"delay":0,"ttmEps":12.289877,"open":789.1,"prevYearClose":772,"prevWeekClose":793.01,"prevMonthClose":779.53,"prevQuarterClose":779.53,"fiveDayClose":772.87,"twentyDayClose":812.03,"sixtyDayClose":757.18,"earningDate":1754496000000,"earningTime":"盘前"},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LLY\",pageSize:20,pageCount:17,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2529826878","title":"減肥藥邁入“吃藥時代”？禮來口服神藥試驗成功，股價飆漲創25年新高！","url":"https://stock-news.laohu8.com/highlight/detail?id=2529826878","media":"金十数据","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529826878?lang=zh_tw&edition=fundamental","pubTime":"2025-04-21 16:25","pubTimestamp":1745223912,"startTime":"0","endTime":"0","summary":"在公布一种用于2型糖尿病和肥胖治疗的GLP-1药物口服剂型的三期试验取得积极成果后，礼来股价周四暴涨14%，创下近25年来最大单日涨幅。礼来在声明中指出，这是首个成功完成三期试验的小分子口服GLP-1受体激动剂。周四，Viking股价下跌1.7%，Terns上涨4.5%。同时，试验中未出现肝损伤报告，最高剂量下的不良反应导致8%的受试者中止治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042116252294dca5d0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042116252294dca5d0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2552382058.USD","SG9999015978.USD","LLY","SG9999015952.SGD","LU0471298694.HKD","LU2106854487.HKD","SG9999018865.SGD","LU2552382132.HKD","GB00BDT5M118.USD","LU0466842654.USD","LU1366192091.USD","SGXZ99366536.SGD","LU0097036916.USD","LU1232071149.USD","LU0882574139.USD","LU1814569148.SGD","LU0238689110.USD","LU0289739699.SGD","LU2023250504.SGD","LU0456855351.SGD","SG9999013999.USD","LU2361044865.SGD","IE00B4R5TH58.HKD","LU0385154629.USD","LU2237438978.USD","LU0820561909.HKD","LU0079474960.USD","LU2237443465.HKD","SG9999001176.USD","BK4007","LU2471134879.HKD","LU2063271972.USD","SGXZ81514606.USD","IE00B1BXHZ80.USD","IE00BFTCPJ56.SGD","SG9999015945.SGD","LU2750360641.GBP","BK4585","LU0256863902.USD","LU0708995401.HKD","LU0823416689.USD","LU1061106388.HKD","BK4599","LU1035775433.USD","LU1868836914.USD","LU2471134952.CNY","LU2324357040.USD","LU1267930730.SGD","LU1712237335.SGD","SGXZ51526630.SGD"],"gpt_icon":1},{"id":"2529484485","title":"海外市場 | 美股繼續調整，禮來口服減肥藥火爆","url":"https://stock-news.laohu8.com/highlight/detail?id=2529484485","media":"Ofweek维科网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529484485?lang=zh_tw&edition=fundamental","pubTime":"2025-04-21 13:48","pubTimestamp":1745214520,"startTime":"0","endTime":"0","summary":"美股三大指数延续调整，标普500上周跌1.5%，道指累跌2.7%，纳指跌幅超2.6%，科技股成主要拖累。微软、谷歌等科技巨头普遍下跌；礼来因口服减肥药进展大涨。美联储鹰派表态叠加关税扰动压制市场情绪，资金加速流出美股。纳斯达克金龙指数周跌0.5%，霸王茶姬美股IPO首日暴涨近16%，中概股短期受关税政策与流动性回流双重影响。机构认为，关税政策落地后美股盈利预期或下修，科技股估值压力未充分释放。欧日股市或延续资金流入优势，黄金、原油等避险资产配置需求升温。相关ETF：纳斯达克ETF（513300）标普ETF（159655）","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042113484694dc8182&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042113484694dc8182&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0354030438.USD","LU0708995401.HKD","LU2265009873.SGD","LU2602419157.SGD","LU0882574139.USD","LU1035775433.USD","BK4585","LU1868836757.USD","LU0006306889.USD","BK4534","LU1127390331.HKD","LU0823416689.USD","LU2089984988.USD","LU2237443382.USD","SG9999015978.USD","LU0096364046.USD","LU0471298694.HKD","SG9999001176.USD","SGXZ99366536.SGD","LU1804176565.USD","BK4599","LU0385154629.USD","IE0002141913.USD","LU1551013425.SGD","LU0354030511.USD","LU2361044949.HKD","LU0466842654.USD","LU2471134952.CNY","LU0203201768.USD","LU2361044865.SGD","LU0114720955.EUR","LU2750360641.GBP","LU0882574055.USD","LLY","LU1623119135.USD","BK4533","IE00B2B36J28.USD","LU1061106388.HKD","LU1057294990.SGD","LU1551013342.USD","LU2324357040.USD","SG9999001176.SGD","LU0058720904.USD","LU2237438978.USD","LU1291159041.SGD","LU2552382215.SGD","LU2357305700.SGD","LU0820561909.HKD","GB00BDT5M118.USD","BK4007"],"gpt_icon":0},{"id":"2529177858","title":"GLP-1競爭新動向：禮來後來居上？","url":"https://stock-news.laohu8.com/highlight/detail?id=2529177858","media":"健识局","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529177858?lang=zh_tw&edition=fundamental","pubTime":"2025-04-21 11:05","pubTimestamp":1745204734,"startTime":"0","endTime":"0","summary":"尽管GLP-1火遍全球，但实际上，现在还没有任何一款GLP-1口服版药物获批了减重适应症。GLP-1尽管看来已经接近完美，但依然有很大的不足。口服药就完全规避了以上所有劣势，从诺和诺德、礼来的开发劲头可以看出，今后GLP-1药物的竞争会逐渐从注射剂转到口服制剂上。口服减肥GLP-1可能会成为礼来反超的一张王牌。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421110753a4606b12&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421110753a4606b12&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1069344957.HKD","SG9999014906.USD","LU1366192091.USD","LU1548497426.USD","SG9999015945.SGD","LU0943347566.SGD","LU1983299246.USD","LU1868837300.USD","BK4007","LU2471134796.USD","LU0882574055.USD","LU1868837136.USD","LU0256863902.USD","LU0006306889.USD","LU1868836591.USD","LU2471134523.USD","LU1974910355.USD","LU2237438978.USD","LU2461242641.AUD","LU2361044949.HKD","LLY","LU1291159041.SGD","IE00BJJMRZ35.SGD","LU2112291526.USD","LU1127390331.HKD","LU1551013425.SGD","LU2324357040.USD","IE00BJT1NW94.SGD","LU0096364046.USD","LU1988902786.USD","LU2491049909.HKD","NVO","SGXZ51526630.SGD","IE00B1BXHZ80.USD","LU0094547139.USD","LU0471298777.SGD","LU2237443895.HKD","LU1551013342.USD","SG9999001176.SGD","LU2237443465.HKD","LU2552382132.HKD","LU0114720955.EUR","LU1868836914.USD","GLP","LU0122379950.USD","SG9999014914.USD","LU0672654240.SGD","LU1917777945.USD","LU2063271972.USD","LU2471134952.CNY","SG9999001176.USD"],"gpt_icon":1},{"id":"1149398083","title":"一週美股牛榜 | 禮來飆升15%；美元樹升10%；德文能源、阿帕契、慧與科技升逾7%","url":"https://stock-news.laohu8.com/highlight/detail?id=1149398083","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1149398083?lang=zh_tw&edition=fundamental","pubTime":"2025-04-21 10:53","pubTimestamp":1745203990,"startTime":"0","endTime":"0","summary":"4月14日至15日期间，其以每股72.50至72.8269美元价格累计购入17,000股，总值约124万美元。美国制裁伊朗原油中国买家 油价应声上涨上周三原油期货逆科技股颓势强势收高。$慧与科技$获埃利奥特超15亿美元持股 股价跳涨据知情人士透露，埃利奥特投资管理公司已建立价值超15亿美元的 $慧与科技$多头仓位。","market":"us","thumbnail":"https://static.tigerbbs.com/2a3253accc7322a3db322a8557ee9834","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/2a3253accc7322a3db322a8557ee9834"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DVN","LLY","HPE","DLTR","APA"],"gpt_icon":1},{"id":"2528386165","title":"醫藥行業週報：禮來首個小分子口服GLP-1藥物3期臨牀研究成功 有望改變減重藥物格局","url":"https://stock-news.laohu8.com/highlight/detail?id=2528386165","media":"平安证券股份有...","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528386165?lang=zh_tw&edition=fundamental","pubTime":"2025-04-20 00:00","pubTimestamp":1745078400,"startTime":"0","endTime":"0","summary":"行业观点礼来首个小分子口服GLP-1药物3期临床研究成功，有望改变减重药物格局4月17日，全球制药巨头礼来公司公布了3期临床研究ACHIEVE-1的积极顶线结果，该研究评估了Orforglipron与安慰剂相比，在患有2型糖尿病和仅通过饮食和运动控制不足的成人中的安全性和有效性。鉴于患者在研究结束时尚未达到体重平台期，可能表明尚未实现完全减重。公司目前也在研究Orforglipron对非糖尿病患者的减重效果。若获批，Orforglipron将成为第二款在美国上市的GLP-1口服药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250420221112973e6626&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250420221112973e6626&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0689472784.USD","LU0094547139.USD","LU1988902786.USD","IE00BK4W5L77.USD","SGXZ99366536.SGD","LU2361044865.SGD","LU1868837136.USD","LU2750360641.GBP","LU2237443978.SGD","LU2471134796.USD","BK4581","IE00B1BXHZ80.USD","IE00BJJMRZ35.SGD","LU1093756168.USD","LU2461242641.AUD","LU2237443549.SGD","LU0672654240.SGD","LU2552382215.SGD","SG9999001176.USD","LU0820561909.HKD","LLY","SG9999017495.SGD","LU0708995401.HKD","IE0009355771.USD","LU0203202063.USD","LU0097036916.USD","LU0882574139.USD","LU0079474960.USD","LU1814569148.SGD","LU1989771016.USD","SGXZ57979304.SGD","LU1551013342.USD","LU1720051108.HKD","LU0061475181.USD","LU0471298694.HKD","LU1291159041.SGD","LU2237443895.HKD","LU0096364046.USD","LU2023250504.SGD","LU1983299246.USD","LU0456855351.SGD","GLP","LU1868836757.USD","IE00BJLML261.HKD","LU2491049909.HKD","LU1280957306.USD","LU1917777945.USD","LU1232071149.USD","BK4585","LU0203201768.USD"],"gpt_icon":1},{"id":"2528003866","title":"醫藥行業週報：本週醫藥下跌0.4% 人民時評要求保證藥企藥店利潤空間 禮來口服GLP-1治療糖尿病研發成功","url":"https://stock-news.laohu8.com/highlight/detail?id=2528003866","media":"上海申银万国证...","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528003866?lang=zh_tw&edition=fundamental","pubTime":"2025-04-20 00:00","pubTimestamp":1745078400,"startTime":"0","endTime":"0","summary":"礼来口服GLP-1 治疗糖尿病研发成功：4 月17 日，礼来宣布首个小分子口服GLP-1RA药物Orforglipron 3 期临床研究成功，ACHIEVE-1 取得了积极的顶线结果。Orforglipron 成为了首个成功完成3 期试验、对饮食或饮水不加以限制的口服小分子GLP-1 受体激动剂。礼来预计将在今年年底前向全球监管机构提交Orforglipron 用于体重管理的上市申请，预计于2026 年提交其用于治疗2 型糖尿病的上市申请。要求国会山调整IRA 药品谈判，旨在进一步降低处方药价格。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042021145194dbdd41&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042021145194dbdd41&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SGXZ51526630.SGD","LU1551013425.SGD","SG9999013999.USD","LU2264538146.SGD","LU2471134879.HKD","LU0882574055.USD","IE0002141913.USD","LU2237443978.SGD","GLP","BK4534","LU0882574139.USD","LU1093756325.SGD","SG9999015978.USD","LU0079474960.USD","LU1366192091.USD","IE00BK4W5L77.USD","LU2552382215.SGD","LU2265009873.SGD","LU1868836757.USD","IE00BJJMRZ35.SGD","LU0058720904.USD","LU1548497426.USD","LU1814569148.SGD","SGXZ57979304.SGD","LU0354030438.USD","LU0708995401.HKD","SGXZ81514606.USD","LU0820561818.USD","LU2237443382.USD","LU2211815571.USD","LU0061475181.USD","LLY","BK4533","BK4590","LU0689472784.USD","LU2361044949.HKD","LU0109391861.USD","LU1917777945.USD","LU1868836914.USD","IE00B4R5TH58.HKD","LU1623119135.USD","LU2461242641.AUD","LU1064131342.USD","LU1061106388.HKD","LU2491050154.USD","LU2089984988.USD","LU0820561909.HKD","LU1868837300.USD","IE00BK4W5M84.HKD","LU0385154629.USD"],"gpt_icon":1},{"id":"2528107268","title":"諾和諾德、禮來“二王爭霸”，國產GLP-1搶奪新適應症，恆瑞醫藥們不想只做減肥神藥","url":"https://stock-news.laohu8.com/highlight/detail?id=2528107268","media":"时代财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528107268?lang=zh_tw&edition=fundamental","pubTime":"2025-04-19 17:46","pubTimestamp":1745055988,"startTime":"0","endTime":"0","summary":"GLP-1（胰高血糖素样肽-1）类药物的适应症不只停留在糖尿病与减重领域，赛道中的玩家们正在加速向其他代谢性疾病及神经系统等更广阔的领域扩围。4月14日，药物临床试验登记与信息公示平台官网显示，信达生物（01801.HK）登记了一项评估玛仕度肽（IBI362）在患有中重度阻塞性睡眠呼吸暂停且肥胖的受试者中有效性和安全性的Ⅲ期临床试验（GLORY-OSA）。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202504193381946449.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1551013425.SGD","LU1069344957.HKD","LU1712237335.SGD","LU2360106947.USD","LU0385154629.USD","LU1988902786.USD","IE00BJT1NW94.SGD","LU2552382215.SGD","LU2264538146.SGD","LU0114720955.EUR","LU0471298694.HKD","GLP","LU0943347566.SGD","LU1023059063.AUD","LU1868837136.USD","BK4533","LU2361045086.USD","LLY","LU0203202063.USD","LU0079474960.USD","LU0198837287.USD","LU1917777945.USD","BK4007","IE0009355771.USD","LU0689472784.USD","SGXZ57979304.SGD","BK4599","LU1548497426.USD","LU2471134523.USD","LU0471298777.SGD","SG9999015986.USD","LU0466842654.USD","NVO","BK4590","SGXZ99366536.SGD","BK4585","SG9999013999.USD","LU1057294990.SGD","LU0238689110.USD","LU1868837300.USD","LU0708995401.HKD","LU2361044865.SGD","SG9999014914.USD","LU0096364046.USD","LU2468319806.SGD","IE00BK4W5M84.HKD","LU1093756168.USD","LU1989771016.USD","LU2237438978.USD","LU0256863811.USD"],"gpt_icon":1},{"id":"2528096721","title":"減重GLP-1製劑將進入每日一次“口服”時代 禮來回應：已在準備產能計劃","url":"https://stock-news.laohu8.com/highlight/detail?id=2528096721","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528096721?lang=zh_tw&edition=fundamental","pubTime":"2025-04-18 23:22","pubTimestamp":1744989770,"startTime":"0","endTime":"0","summary":"4月17日，礼来制药公布旗下口服GLP-1（胰高血糖素样肽-1）制剂“Orforglipron”的临床数据，在最高剂量下，每日服用一次Orforglipron的患者实现了平均减重7.3kg（7.9%）。这一表现超过了礼来之前预计的减重范围。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202504183381594279.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202504183381594279.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU2602419157.SGD","LU0466842654.USD","LU0238689110.USD","LU1712237335.SGD","GLP","LU2023250504.SGD","SG9999001176.USD","SG9999014914.USD","SGXZ81514606.USD","LU0708995401.HKD","LU0006306889.USD","LU0471298777.SGD","LU0882574139.USD","LU1623119135.USD","LLY","LU1868836591.USD","LU2471134879.HKD","LU2324357040.USD","LU1868836914.USD","LU1551013342.USD","LU1127390331.HKD","LU2211815571.USD","LU2491050154.USD","LU2491050071.SGD","LU2063271972.USD","LU2471134523.USD","LU0079474960.USD","LU1267930730.SGD","LU2265009873.SGD","SGXZ31699556.SGD","BK4533","BK4590","LU1061106388.HKD","LU0943347566.SGD","SG9999014898.SGD","SG9999018857.SGD","LU0096364046.USD","LU1983299246.USD","SG9999015945.SGD","LU0114720955.EUR","LU1720051017.SGD","LU1064131342.USD","LU0106261372.USD","LU2089984988.USD","SG9999014906.USD","IE00BFTCPJ56.SGD","LU0385154629.USD","SGXZ51526630.SGD","LU2361044949.HKD","LU1974910355.USD"],"gpt_icon":1},{"id":"1188540307","title":"禮來預計年底前向全球監管機構提交新款減肥藥的上市申請","url":"https://stock-news.laohu8.com/highlight/detail?id=1188540307","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1188540307?lang=zh_tw&edition=fundamental","pubTime":"2025-04-18 17:42","pubTimestamp":1744969324,"startTime":"0","endTime":"0","summary":"礼来公布了3期临床研究的积极顶线结果。","market":"us","thumbnail":"https://static.tigerbbs.com/25bb080e73b6be662c435ea6aeaec9c7","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/25bb080e73b6be662c435ea6aeaec9c7"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LLY"],"gpt_icon":0},{"id":"2528059212","title":"禮來公佈口服降糖藥積極結果，或年底前提交用於體重管理上市申請","url":"https://stock-news.laohu8.com/highlight/detail?id=2528059212","media":"澎湃新闻","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528059212?lang=zh_tw&edition=fundamental","pubTime":"2025-04-18 17:20","pubTimestamp":1744968000,"startTime":"0","endTime":"0","summary":"“GLP-1双雄”之一的礼来公布口服小分子GLP-1药物orforglipron在糖尿病领域的积极研究结果，也让行业对口服小分子减肥药充满期待。当地时间4月17日，礼来公布3期临床研究ACHIEVE-1的积极顶线结果，该研究评估了orforglipron对比安慰剂，在饮食控制和运动基础上血糖控制仍不佳的2型糖尿病患者中的安全性和有效性。礼来预计将在今年年底前向全球监管机构提交orforglipron用于体重管理的上市申请，预计于2026年提交其用于治疗2型糖尿病的上市申请。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041817225394d9e907&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041817225394d9e907&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0354030438.USD","LU2361045086.USD","LU2360106947.USD","LU0203202063.USD","LU0882574055.USD","LU2552382132.HKD","LU0114720955.EUR","IE00B4R5TH58.HKD","LU0079474960.USD","LU0256863902.USD","LU1057294990.SGD","LU1868836757.USD","SGXZ57979304.SGD","LU1548497426.USD","LU1804176565.USD","LU1291159041.SGD","IE00BFTCPJ56.SGD","IE0004445239.USD","IE00BK4W5L77.USD","IE00BJJMRZ35.SGD","LU2491050071.SGD","LU1061106388.HKD","LU2264538146.SGD","LU1280957306.USD","LU2324357040.USD","LU0256863811.USD","LU1868837136.USD","LU1974910355.USD","LU0689472784.USD","LLY","LU0823416689.USD","LU1551013425.SGD","LU2023250504.SGD","LU0096364046.USD","LU2750360641.GBP","LU2237438978.USD","SG9999015986.USD","LU0203201768.USD","SGXZ51526630.SGD","LU0820561818.USD","LU1551013342.USD","LU1035775433.USD","SGXZ81514606.USD","LU2361044865.SGD","BK4533","LU0106261372.USD","SG9999015952.SGD","LU1988902786.USD","IE0009355771.USD","LU1868836591.USD"],"gpt_icon":1},{"id":"2528310650","title":"大摩：口服減肥藥Orforglipron成股價推動力 禮來還能再漲34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2528310650","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528310650?lang=zh_tw&edition=fundamental","pubTime":"2025-04-18 15:54","pubTimestamp":1744962872,"startTime":"0","endTime":"0","summary":"礼来最近公布，其口服减肥药Orforglipron在三期临床试验中表现出色，该药物在减肥效果上可以媲美甚至超越注射型GLP-1药物，摩根士丹利将这一消息视为礼来股票的积极催化剂。试验结果显示，服用Orforglipron的患者平均减轻16磅，相当于体重的7.9%。试验结果还显示，Orforglipron整体安全性和已上市GLP-1类药物一致，主要不良反应为腹泻、恶心等胃肠道反应，未观察到肝安全性风险信号。市场前景方面，摩根士丹利预计Orforglipron 2033年销售额将达到约70亿美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250418160308973c512f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250418160308973c512f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BK4W5M84.HKD","IE0009355771.USD","LU2360106947.USD","LU2468319806.SGD","LU0354030511.USD","LU0795875086.SGD","LU2471134796.USD","LU0096364046.USD","LU2750360997.AUD","IE00B4R5TH58.HKD","BK4007","LU1983299246.USD","SGXZ31699556.SGD","LU1988902786.USD","LU0456855351.SGD","LU0882574055.USD","LU2361045086.USD","LU2237443465.HKD","IE00BK4W5L77.USD","LU2361044865.SGD","LU2324357040.USD","SG9999015978.USD","IE00B2B36J28.USD","LU1720051108.HKD","SG9999013999.USD","LU2237443895.HKD","LU1093756168.USD","LU2471134523.USD","BK4127","LU0158827781.USD","LU2361044949.HKD","LU2471134952.CNY","LU0098860793.USD","SG9999001176.USD","LU2471134879.HKD","LU0114720955.EUR","LLY","LU0354030438.USD","LU2491049909.HKD","LU2750360641.GBP","BK4516","SGXZ81514606.USD","SG9999001176.SGD","LU1804176565.USD","IE00BKVL7J92.USD","LU2271345857.HKD","IE00BJLML261.HKD","LU0385154629.USD","BK4581","LU0320765646.SGD"],"gpt_icon":1},{"id":"2528398720","title":"GLP-1減肥藥市場博弈：禮來領航突破、輝瑞折戟沉沙，創新戰如何取勝？","url":"https://stock-news.laohu8.com/highlight/detail?id=2528398720","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528398720?lang=zh_tw&edition=fundamental","pubTime":"2025-04-18 15:37","pubTimestamp":1744961820,"startTime":"0","endTime":"0","summary":"全球GLP-1减肥药市场正迎来新一轮格局重塑。礼来在GLP-1赛道实现突破性进展之际，辉瑞却因安全性问题终止了口服GLP-1药物Danuglipron的研发，这也标志着其在该赛道的再次失利。在安全性方面，ACHIEVE-1研究中，orforglipron的整体安全性与GLP-1类药物一致。在礼来有效性、安全性均获得较好反响的同时，辉瑞安全性问题致口服赛道折戟。这是辉瑞在GLP-1减重药上的再次折戟。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041815395094d9c96c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041815395094d9c96c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1127390331.HKD","LU0417517546.SGD","BK4581","LU0122379950.USD","SGXZ51526630.SGD","LU2750360641.GBP","IE00BLSP4239.USD","LU1061106388.HKD","LU0203201768.USD","LU0820561818.USD","IE00BJJMRZ35.SGD","LU1868836914.USD","LU1894683264.USD","BK4516","LU0321505439.SGD","SG9999013999.USD","LLY","LU2471134879.HKD","BK4007","SGXZ99366536.SGD","LU0234572021.USD","LU0238689110.USD","LU0109391861.USD","BK4533","LU1720051108.HKD","LU2360106947.USD","SGXZ31699556.SGD","LU0943347566.SGD","LU1551013425.SGD","LU1983299246.USD","LU2264538146.SGD","PFE","LU2237443622.USD","LU2237443895.HKD","LU0708995401.HKD","LU1988902786.USD","LU1868836757.USD","LU1057294990.SGD","SG9999015986.USD","SG9999017495.SGD","LU1917777945.USD","IE00B1BXHZ80.USD","LU2106854487.HKD","BK4599","LU1974910355.USD","SG9999015945.SGD","BK4588","LU2357305700.SGD","IE00BK4W5L77.USD","GLP"],"gpt_icon":1},{"id":"2528080431","title":"禮來首個小分子口服GLP-1藥物3期臨牀研究成功 有望顛覆減重藥物格局","url":"https://stock-news.laohu8.com/highlight/detail?id=2528080431","media":"证券日报","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528080431?lang=zh_tw&edition=fundamental","pubTime":"2025-04-18 14:07","pubTimestamp":1744956431,"startTime":"0","endTime":"0","summary":"本报讯（记者李春莲见习记者梁傲男）4月17日，全球制药巨头礼来公司公布了3期临床研究ACHIEVE-1的积极顶线结果，该研究评估了Orforglipron与安慰剂相比，在患有2型糖尿病和仅通过饮食和运动控制不足的成人中的安全性和有效性。4月17日，礼来股价收涨超14%，创下自2023年8月份以来的最大单日涨幅。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202504183381169424.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1093756168.USD","LU1280957306.USD","IE0004445239.USD","LU0417517546.SGD","LU2237438978.USD","LU2237443465.HKD","LU2211815571.USD","LU0203202063.USD","LU2357305700.SGD","LU2468319806.SGD","LU0289739699.SGD","BK4581","LU0820561818.USD","SGXZ31699556.SGD","LU1720051108.HKD","SG9999014880.SGD","IE00B2B36J28.USD","LU1064131342.USD","LU2471134523.USD","SG9999018865.SGD","LU1814569148.SGD","IE00BK4W5L77.USD","BK4533","LU2237443549.SGD","LU1057294990.SGD","LU1232071149.USD","LU1127390331.HKD","LU0061475181.USD","LLY","LU0882574055.USD","IE0009355771.USD","GLP","LU0006306889.USD","LU2552382132.HKD","LU0094547139.USD","SG9999015945.SGD","SG9999013999.USD","LU1988902786.USD","LU0385154629.USD","LU0471298694.HKD","LU1366192091.USD","LU0079474960.USD","LU1023059063.AUD","SG9999014898.SGD","IE00BK4W5M84.HKD","LU1983299246.USD","LU0689472784.USD","LU0114720955.EUR","SG9999017495.SGD","IE00BJLML261.HKD"],"gpt_icon":1},{"id":"2528076427","title":"禮來4月17日成交額為91.53億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2528076427","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528076427?lang=zh_tw&edition=fundamental","pubTime":"2025-04-18 09:53","pubTimestamp":1744941197,"startTime":"0","endTime":"0","summary":"美东时间2025年4月17日，礼来成交额为91.53亿美元，成交额较昨日增加275.58%，当日成交量为1085.34万股。礼来于2025年4月17日涨14.3%，报839.96美元，该股过去5个交易日涨16.51%，年初至今涨8.99%，过去60日涨11.59%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-04-17|91.53亿|275.58%|1085.34万|#|2025-04-16|24.37亿|30.87%|330.26万|#|2025-04-15|18.62亿|-28.31%|245.81万|#|2025-04-14|25.98亿|-0.95%|346.12万|#|2025-04-11|26.23亿|-12.56%|360.34万|礼来制药公司是一家专注于神经科学、心脏代谢、癌症和免疫学的制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250418095319a6beaf60&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250418095319a6beaf60&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2237443382.USD","SG9999014914.USD","LU1093756325.SGD","LU2237443895.HKD","LU0456855351.SGD","LU0289739699.SGD","LU1989771016.USD","LU2106854487.HKD","LU0882574139.USD","IE00BK4W5L77.USD","LU0820561818.USD","LU1291159041.SGD","LU2750360641.GBP","LU2552382132.HKD","LU1983299246.USD","LU2461242641.AUD","LU0640476718.USD","LU2602419157.SGD","LU2264538146.SGD","SG9999015986.USD","LU1232071149.USD","LU1868836757.USD","LU1035775433.USD","IE0009355771.USD","LU0256863902.USD","LU1804176565.USD","LU2750360997.AUD","LU0689472784.USD","LU0354030438.USD","IE0004445239.USD","BK4588","LU0471298777.SGD","LU1061106388.HKD","LU2491050154.USD","LU1551013425.SGD","LU2211815571.USD","LU1868836591.USD","LU2471134879.HKD","SG9999001176.SGD","SG9999015978.USD","LU2265009873.SGD","LU1093756168.USD","LU0354030511.USD","LU2491050071.SGD","LLY","BK4534","LU0079474960.USD","LU2089984988.USD","LU0672654240.SGD","LU0943347566.SGD"],"gpt_icon":1},{"id":"1170316139","title":"“減肥神藥”進入口服時代，禮來登頂“減肥藥王”？","url":"https://stock-news.laohu8.com/highlight/detail?id=1170316139","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1170316139?lang=zh_tw&edition=fundamental","pubTime":"2025-04-18 09:36","pubTimestamp":1744940179,"startTime":"0","endTime":"0","summary":"数据显示，服用Orforglipron的参与者在40周后平均减轻了16磅，约占体重的7.9%，这一表现超过了礼来之前预计的4%至7%减重范围。华尔街分析师普遍认为，GLP-1减肥药领域正在从注射剂型向便捷的口服形式转变，而礼来已经取得了早期领先优势。登顶减肥药之王？报道称，辉瑞的退出进一步巩固了礼来在这一领域的领先地位。根据临床试验数据库，礼来公司的主要肥胖症试验最早将于7月完成。","market":"us","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":{"source":"wallstreetcn_api","url":"https://wallstreetcn.com/articles/3745456","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3745456","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"“减肥神药”进入口服时代，礼来登顶“减肥药王”？","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"wallstreetcn_api","symbols":["LU0256863811.USD","IE0004445239.USD","LU0289739699.SGD","LU0198837287.USD","LU0823416689.USD","IE00BJJMRZ35.SGD","LU0385154629.USD","BK4516","LLY","IE00B4R5TH58.HKD","LU0943347566.SGD","IE0009355771.USD","BK4581","IE00BFTCPJ56.SGD","LU0456855351.SGD","LU0708995401.HKD","LU0882574139.USD","LU0061475181.USD","LU0820561818.USD","IE0002141913.USD"],"gpt_icon":0},{"id":"2528708741","title":"美聯邦法官裁定谷歌非法壟斷部分廣告技術市場；禮來首款GLP-1口服藥報告積極三期試驗結果丨全球科技早參","url":"https://stock-news.laohu8.com/highlight/detail?id=2528708741","media":"每日经济新闻","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528708741?lang=zh_tw&edition=fundamental","pubTime":"2025-04-18 07:59","pubTimestamp":1744934384,"startTime":"0","endTime":"0","summary":"｜2025年4月18日星期五｜NO.1美联邦法官裁定谷歌非法垄断部分广告技术市场当地时间4月17日，美国一位联邦法官表示，谷歌公司非法垄断了两个在线广告技术市场。据悉，该裁决为检察官能够主张拆分谷歌公司的广告产品提供了可能性。当天晚些时候，谷歌在一份声明中表示，将对上述裁决提起上诉，称不同意法院关于其发布商工具的裁决。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202504183380604595.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202504183380604595.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1506573853.SGD","LU2471134952.CNY","LU0006306889.USD","SG9999014898.SGD","LU0203202063.USD","SGXZ31699556.SGD","LLY","LU0308772762.SGD","LU0788109477.HKD","LU2360106947.USD","LU2097344357.USD","LU0690374961.EUR","LU0175139822.USD","LU1267930490.SGD","LU1435385759.SGD","GOOG","LU0690374615.EUR","LU0385154629.USD","GOOGL","IE00BJTD4N35.SGD","LU0444971666.USD","BK4550","LU1066051498.USD","LU2242650005.HKD","GLP","SG9999014880.SGD","LU0122379950.USD","USJW.SI","IE00BK4W5L77.USD","LU0557290698.USD","LU0128525689.USD","LU1244550494.USD","LU1814569148.SGD","LU2362541513.USD","LU0082616367.USD","LU0251142724.SGD","GB00BDT5M118.USD","LU0314106906.USD","LU2362541273.HKD","LU2404859667.USD","LU0957791311.USD","LU1691799644.USD","LU0648001328.SGD","LU0114720955.EUR","LU0251132253.USD","LU0225283273.USD","LU0234570918.USD","LU1699723380.USD","IE00BYQQ9H92.USD","LU0238689110.USD"],"gpt_icon":1},{"id":"2528377648","title":"美國股市：三大股指在震盪交投中漲跌互現，投資者評估貿易磋商和利率前景","url":"https://stock-news.laohu8.com/highlight/detail?id=2528377648","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528377648?lang=zh_tw&edition=fundamental","pubTime":"2025-04-18 04:55","pubTimestamp":1744923354,"startTime":"0","endTime":"0","summary":"美国股市：三大股指在震荡交投中涨跌互现，投资者评估贸易磋商和利率前景关注美日关税磋商裁决公布后，Alphabet下跌保险公司股下跌，此前联合健康集团公布业绩标普 500 指数收高0.13%，纳指收低0.13%，道指收挫1.33%. 自4月2日特朗普宣布全面征收全球关税以来，标普500指数已经下跌约7%。\"美国股市周五将休市，华尔街三大股指均录得四周以来的第三次周线下跌。两只标普 500 指数成分股创下新高，两只创新低。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250417:nL6T3QV0S6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765059.SGD","BK4527","LU0208291251.USD","CVS","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","MACW.SI","IE00B7KXQ091.USD","LU1935042488.USD","LU0426417589.USD","IE000KEQY171.SGD","LU2420271590.USD","LU2347655156.SGD","LU0471298694.HKD","LU1127390331.HKD","BK4551","LU0061475181.USD","LU0211326839.USD","LU2404859667.USD","SGXZ57979304.SGD","LU1221951129.SGD","LLY","IE00B775SV38.USD","LU2404859741.USD","UNH","LU0265550946.USD","LU0861579265.USD","LU0256863811.USD","LU0390134368.USD","LU2237443465.HKD","IE00B3SWFQ91.USD","LU1366333091.USD","LU0316494557.USD","LU1791710400.SGD","LU0079474960.USD","LU1066051498.USD","BK4196","LU2456880835.USD","LU2326559502.SGD","LU0211331839.USD","LU0061474705.USD","LU1244550494.USD","HUM","LU0345768153.USD","LU0289739343.SGD"],"gpt_icon":1},{"id":"2528080941","title":"太平洋醫藥日報：禮來口服GLP-1受體激動劑ORFORGLIPRON三期臨牀成功","url":"https://stock-news.laohu8.com/highlight/detail?id=2528080941","media":"太平洋证券股份...","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528080941?lang=zh_tw&edition=fundamental","pubTime":"2025-04-18 00:00","pubTimestamp":1744905600,"startTime":"0","endTime":"0","summary":"行业要闻：4 月17 日，礼来宣布，公司口服GLP-1受体激动剂Orforglipron 奥格列龙在一项关键的III 期临床试验中取得了具有统计学意义的积极结果。这项研究评估了Orforglipron 与安慰剂相比，在仅通过饮食和运动控制血糖不佳的成人2 型糖尿病患者中的安全性和有效性。Orforglipron 是一种研究性的、每日一次口服的小分子（非肽）胰高血糖素样肽-1 受体激动剂，可在一天中的任何时间服用，且不受食物和饮水限制。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041814031994d9b2b4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041814031994d9b2b4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2106854487.HKD","LU2602419157.SGD","LU2237443465.HKD","BK4581","LU0882574139.USD","LU1232071149.USD","GLP","LU2361044949.HKD","IE00BK4W5M84.HKD","SG9999001176.SGD","SG9999001176.USD","LU0203201768.USD","LU0256863902.USD","BK4516","IE0002141913.USD","LU2112291526.USD","LU2491050154.USD","LU1023059063.AUD","LU2063271972.USD","LU1868836591.USD","LU2468319806.SGD","BK4007","LU0320765059.SGD","LU1868836757.USD","LU1720051108.HKD","LU2237438978.USD","LU2237443382.USD","LLY","LU1291159041.SGD","LU1989771016.USD","LU2471134796.USD","LU0466842654.USD","BK4590","SGXZ57979304.SGD","LU0354030438.USD","LU1917777945.USD","LU1093756325.SGD","SG9999014914.USD","SG9999015952.SGD","SGXZ99366536.SGD","LU2237443549.SGD","LU0238689110.USD","LU1974910355.USD","LU0708995401.HKD","LU2211815571.USD","LU2750360997.AUD","SG9999015945.SGD","LU1057294990.SGD","LU1868837136.USD","LU2360106947.USD"],"gpt_icon":1},{"id":"2528575741","title":"美股異動 | 口服減肥藥Orforglipron三期臨牀數據亮眼 禮來(LLY.US)漲逾13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2528575741","media":"智通财经","labels":["dataReport","movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528575741?lang=zh_tw&edition=fundamental","pubTime":"2025-04-17 22:37","pubTimestamp":1744900651,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，周四，礼来(LLY.US)涨逾13%，报833.45美元。消息面上，礼来口服减肥药Orforglipron在三期临床试验中表现出色，有望成为无需注射的减肥药替代品。试验结果显示，礼来的Orforglipron在减肥效果上可以媲美甚至超越注射型GLP-1药物。服用Orforglipron的患者平均减轻16磅，相当于体重的7.9%。相比之下，诺和诺德的明星产品Ozempic在最高剂量下糖尿病患者仅减轻约6%的体重。此外，这款口服药还平均降低了血糖水平1.3%，而Ozempic降低了2.1%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1280531.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1868836757.USD","LU1988902786.USD","LU0203202063.USD","LU0672654240.SGD","BK4533","LU0238689110.USD","LU1267930730.SGD","LU2112291526.USD","LU2491049909.HKD","LU2237443549.SGD","LU0256863902.USD","LU0471298694.HKD","LU1023059063.AUD","LU0122379950.USD","LU0203201768.USD","LU0354030511.USD","SGXZ99366536.SGD","LU0256863811.USD","LU2552382132.HKD","LU0708995401.HKD","LU2361044865.SGD","LU1061106388.HKD","SG9999015978.USD","LU2237438978.USD","LU1814569148.SGD","LU2237443382.USD","LU2237443978.SGD","SG9999018857.SGD","IE00BJT1NW94.SGD","LU0943347566.SGD","LU0471298777.SGD","LU0006306889.USD","LU2264538146.SGD","LU2471134523.USD","LU2750360997.AUD","LU0058720904.USD","SG9999001176.SGD","LLY","LU1232071149.USD","BK4581","LU2471134796.USD","LU0097036916.USD","SG9999014880.SGD","IE00BJLML261.HKD","LU2491050154.USD","SGXZ81514606.USD","IE00B1BXHZ80.USD","LU2471134952.CNY","SGXZ57979304.SGD","LU0466842654.USD"],"gpt_icon":0},{"id":"2528743174","title":"禮來(LLY)漲超16% 諾和諾德(NVO)跌逾8% Orforglipron研究取得積極結果","url":"https://stock-news.laohu8.com/highlight/detail?id=2528743174","media":"金吾财讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528743174?lang=zh_tw&edition=fundamental","pubTime":"2025-04-17 21:45","pubTimestamp":1744897552,"startTime":"0","endTime":"0","summary":"与此同时，诺和诺德股价走低，跌8.45%，报57.56美元。消息面上，公司宣布III期ACHIEVE-1研究取得积极结果，该研究评估了orforglipron与安慰剂相比在饮食和运动单独控制不佳的2型糖尿病成人中的安全性和疗效。Orforglipron是首个成功完成III期研究的口服小分子胰高血糖素样肽-1受体激动剂，服用时无需食物和水限制。Orforglipron在后期试验中，最高剂量下可使 2 型糖尿病患者体重减轻16.0 磅，并降低血糖。","market":"us","thumbnail":"https://static.szfiu.com/news/20250107/M2RkMDMzZDc5MTczNjIzNzY2ODA2Mg==.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/M2RkMDMzZDc5MTczNjIzNzY2ODA2Mg==.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"287644","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0004445239.USD","LU0354030511.USD","LU2471134952.CNY","LU0672654240.SGD","LU0385154629.USD","LU2471134523.USD","LU2237443978.SGD","LU2552382132.HKD","LU2237438978.USD","LU2750360997.AUD","BK4585","IE0009355771.USD","LU2491049909.HKD","LU1989771016.USD","LU1093756325.SGD","LU0097036916.USD","SG9999018857.SGD","IE00B1BXHZ80.USD","LU0256863902.USD","LU0689472784.USD","LU2357305700.SGD","LU0823416689.USD","LU0058720904.USD","LU0198837287.USD","LU0354030438.USD","LU1057294990.SGD","SGXZ51526630.SGD","LU2360106947.USD","SG9999014880.SGD","LU2552382215.SGD","BK4532","LU0238689110.USD","SGXZ31699556.SGD","LU1280957306.USD","LU0882574139.USD","SG9999015952.SGD","LU1093756168.USD","LU0708995401.HKD","IE00BK4W5M84.HKD","BK4516","LU1868837300.USD","LU1720051017.SGD","LU1623119135.USD","LU0456855351.SGD","IE0002141913.USD","LU1232071149.USD","SGXZ57979304.SGD","LLY","SG9999014914.USD","NVO"],"gpt_icon":0}],"pageSize":20,"totalPage":20,"pageCount":17,"totalSize":400,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LLY\",params:#limit:5,,,undefined,":[{"date":"2025-08-15","symbol":"LLY","amount":1.5,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-08-15","defaultRemindTime":1755264600000,"name":"礼来","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-10","payableDate":"2025-08-15","currency":"USD","dateTimestamp":1755230400000,"payDate":"2025-09-10"},{"date":"2025-08-07","symbol":"LLY","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2025/06","expectedEps":5.57,"defaultRemindTime":1754553600000,"name":null,"time":"盤前","dateTimestamp":1754539200000,"actualEps":null},{"date":"2025-05-16","symbol":"LLY","amount":1.5,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-05-16","defaultRemindTime":1747402200000,"name":"礼来","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-10","payableDate":"2025-05-16","currency":"USD","dateTimestamp":1747368000000,"payDate":"2025-06-10"},{"market":"US","date":"2025-05-01","symbol":"LLY","fiscalQuarterEnding":"2025/03","expectedEps":3.52,"name":null,"time":"盤前","type":"earning","dateTimestamp":1746072000000,"reportTimeType":"pre","actualEps":3.34},{"date":"2025-02-14","symbol":"LLY","amount":1.5,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-02-14","defaultRemindTime":1739543400000,"name":"礼来","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-10","payableDate":"2025-02-14","currency":"USD","dateTimestamp":1739509200000,"payDate":"2025-03-10"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LLY\",market:\"US\",,,undefined,":[{"executeDate":"2015-08-12","recordDate":"2015-08-14","paymentDate":"2015-09-10","value":0.5,"currency":"USD"},{"executeDate":"2015-11-10","recordDate":"2015-11-13","paymentDate":"2015-12-10","value":0.5,"currency":"USD"},{"executeDate":"2016-02-10","recordDate":"2016-02-12","paymentDate":"2016-03-10","value":0.51,"currency":"USD"},{"executeDate":"2016-05-11","recordDate":"2016-05-13","paymentDate":"2016-06-10","value":0.51,"currency":"USD"},{"executeDate":"2016-08-11","recordDate":"2016-08-15","paymentDate":"2016-09-09","value":0.51,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LLY\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2759,"buy":0.5172,"hold":0.1724,"sell":0.0345,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5172,"analysts":29,"updateTime":1746158400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/LLY\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"LLY","date":"2025-07-11","current":63.90862,"percent":0.60866,"low":21.223959,"twenty":34.27811,"median":53.946077,"eighty":86.522333,"high":139.115155,"avg":62.486311,"sd":31.970046,"marketCap":709794692463},"quantilePoints":[{"date":"2020-07-17","current":27.187125,"twenty":15.251094,"median":32.585712,"eighty":38.329717,"marketCap":150434516350},{"date":"2020-07-24","current":26.135417,"twenty":15.251094,"median":32.585712,"eighty":38.329717,"marketCap":144615104473},{"date":"2020-07-31","current":24.249022,"twenty":15.251094,"median":32.585712,"eighty":38.329717,"marketCap":136233432207},{"date":"2020-08-07","current":24.674982,"twenty":15.251094,"median":32.585712,"eighty":38.329717,"marketCap":138626513989},{"date":"2020-08-14","current":24.216753,"twenty":15.251094,"median":32.585712,"eighty":38.329717,"marketCap":136052138133},{"date":"2020-08-21","current":24.082834,"twenty":15.251094,"median":32.585712,"eighty":38.329717,"marketCap":135299767724},{"date":"2020-08-28","current":23.773045,"twenty":15.251094,"median":32.585712,"eighty":38.329717,"marketCap":133559344610},{"date":"2020-09-04","current":24.349058,"twenty":15.251094,"median":32.585712,"eighty":38.329717,"marketCap":136795443838},{"date":"2020-09-11","current":23.894056,"twenty":15.251094,"median":32.585712,"eighty":38.329717,"marketCap":134239197389},{"date":"2020-09-18","current":24.875053,"twenty":15.251094,"median":32.585712,"eighty":38.329717,"marketCap":139750537251},{"date":"2020-09-25","current":24.244182,"twenty":15.251094,"median":32.585712,"eighty":38.329717,"marketCap":136206238096},{"date":"2020-10-02","current":23.429373,"twenty":15.251094,"median":32.585712,"eighty":38.329717,"marketCap":131628562718},{"date":"2020-10-09","current":25.312307,"twenty":15.251094,"median":32.585712,"eighty":38.329717,"marketCap":142207071959},{"date":"2020-10-16","current":23.5762,"twenty":15.251094,"median":32.585712,"eighty":38.329717,"marketCap":132453450756},{"date":"2020-10-23","current":22.972758,"twenty":15.251094,"median":32.585712,"eighty":38.329717,"marketCap":129063251565},{"date":"2020-10-30","current":21.223959,"twenty":15.251094,"median":32.585712,"eighty":38.329717,"marketCap":118272635275},{"date":"2020-11-06","current":23.221738,"twenty":15.251094,"median":32.585712,"eighty":38.329717,"marketCap":129405457298},{"date":"2020-11-13","current":23.163171,"twenty":15.251094,"median":32.585712,"eighty":38.329717,"marketCap":129079087923},{"date":"2020-11-20","current":23.669123,"twenty":15.251094,"median":32.518779,"eighty":38.329717,"marketCap":131898556693},{"date":"2020-11-27","current":23.98636,"twenty":15.251094,"median":32.403561,"eighty":38.329717,"marketCap":133666390809},{"date":"2020-12-04","current":24.150673,"twenty":15.251094,"median":32.241495,"eighty":38.329717,"marketCap":134582038223},{"date":"2020-12-11","current":26.036198,"twenty":15.251094,"median":31.923161,"eighty":38.329717,"marketCap":145089318943},{"date":"2020-12-18","current":27.884306,"twenty":15.251094,"median":31.731782,"eighty":38.329717,"marketCap":155388085897},{"date":"2020-12-24","current":27.113177,"twenty":15.251094,"median":30.933068,"eighty":38.329717,"marketCap":151090889122},{"date":"2020-12-31","current":27.467831,"twenty":15.251094,"median":30.534112,"eighty":38.329717,"marketCap":153067237006},{"date":"2021-01-08","current":27.072505,"twenty":15.251094,"median":30.250726,"eighty":38.329717,"marketCap":150864243723},{"date":"2021-01-15","current":31.035526,"twenty":15.251094,"median":30.18994,"eighty":38.329717,"marketCap":172948571450},{"date":"2021-01-22","current":33.536003,"twenty":15.251094,"median":30.18994,"eighty":38.329717,"marketCap":186882730611},{"date":"2021-01-29","current":30.440896,"twenty":15.251094,"median":30.223302,"eighty":38.329717,"marketCap":188541774936},{"date":"2021-02-05","current":29.533392,"twenty":15.251094,"median":30.179801,"eighty":38.329717,"marketCap":182920969028},{"date":"2021-02-12","current":30.341363,"twenty":15.251094,"median":30.18994,"eighty":38.329717,"marketCap":187925299449},{"date":"2021-02-19","current":29.468797,"twenty":15.251094,"median":30.223302,"eighty":38.329717,"marketCap":182520890237},{"date":"2021-02-26","current":30.051075,"twenty":15.251094,"median":30.223302,"eighty":38.329717,"marketCap":186127340238},{"date":"2021-03-05","current":30.348813,"twenty":15.245453,"median":30.2533,"eighty":38.329717,"marketCap":187971444395},{"date":"2021-03-12","current":30.51895,"twenty":15.245453,"median":30.281345,"eighty":38.329717,"marketCap":189025218199},{"date":"2021-03-19","current":27.046542,"twenty":15.245453,"median":30.281345,"eighty":38.329717,"marketCap":167518164982},{"date":"2021-03-26","current":27.196238,"twenty":15.251094,"median":30.2732,"eighty":38.329717,"marketCap":168445336984},{"date":"2021-04-01","current":27.185964,"twenty":15.251094,"median":30.2732,"eighty":38.329717,"marketCap":168381707533},{"date":"2021-04-09","current":27.075894,"twenty":15.245453,"median":30.281345,"eighty":38.329717,"marketCap":167699963413},{"date":"2021-04-16","current":27.774475,"twenty":15.245453,"median":30.281345,"eighty":38.329717,"marketCap":172026766090},{"date":"2021-04-23","current":27.696692,"twenty":15.245453,"median":30.248153,"eighty":38.329717,"marketCap":171545000246},{"date":"2021-04-30","current":27.270017,"twenty":15.245453,"median":30.181429,"eighty":38.329717,"marketCap":166142580765},{"date":"2021-05-07","current":29.157448,"twenty":15.245453,"median":30.118878,"eighty":38.329717,"marketCap":177641752657},{"date":"2021-05-14","current":29.275319,"twenty":15.245453,"median":30.051075,"eighty":38.329717,"marketCap":178359882759},{"date":"2021-05-21","current":29.822898,"twenty":15.245453,"median":29.916885,"eighty":38.329717,"marketCap":181696006146},{"date":"2021-05-28","current":29.802009,"twenty":15.245453,"median":29.887844,"eighty":38.329717,"marketCap":181568742584},{"date":"2021-06-04","current":30.142195,"twenty":15.245453,"median":29.856706,"eighty":38.329717,"marketCap":183641320600},{"date":"2021-06-11","current":33.435127,"twenty":15.245453,"median":29.856706,"eighty":38.329717,"marketCap":203703512194},{"date":"2021-06-18","current":32.608537,"twenty":15.245453,"median":29.856706,"eighty":38.329717,"marketCap":198667511223},{"date":"2021-06-25","current":34.349748,"twenty":15.245453,"median":29.856706,"eighty":38.329717,"marketCap":209275838178},{"date":"2021-07-02","current":34.907771,"twenty":15.245453,"median":29.856706,"eighty":38.329717,"marketCap":212675593346},{"date":"2021-07-09","current":35.061451,"twenty":15.245453,"median":29.856706,"eighty":38.329717,"marketCap":213611889555},{"date":"2021-07-16","current":34.683965,"twenty":15.245453,"median":29.856706,"eighty":38.265046,"marketCap":211312055177},{"date":"2021-07-23","current":36.42816,"twenty":15.245453,"median":29.856706,"eighty":38.222517,"marketCap":221938562640},{"date":"2021-07-30","current":36.331177,"twenty":15.245453,"median":29.856706,"eighty":38.176103,"marketCap":221347696101},{"date":"2021-08-06","current":39.341373,"twenty":15.245453,"median":29.856706,"eighty":38.153191,"marketCap":238829670451},{"date":"2021-08-13","current":39.456362,"twenty":15.245453,"median":29.856706,"eighty":38.153191,"marketCap":239527737739},{"date":"2021-08-20","current":40.456921,"twenty":15.245453,"median":29.856706,"eighty":38.153191,"marketCap":245601829722},{"date":"2021-08-27","current":38.790319,"twenty":15.245453,"median":29.856706,"eighty":38.153191,"marketCap":235484386956},{"date":"2021-09-03","current":38.757464,"twenty":15.245453,"median":29.856706,"eighty":38.153191,"marketCap":235284939160},{"date":"2021-09-10","current":35.766242,"twenty":15.245453,"median":29.856706,"eighty":38.08692,"marketCap":217126123873},{"date":"2021-09-17","current":34.362473,"twenty":15.245453,"median":29.856706,"eighty":37.984151,"marketCap":208604263479},{"date":"2021-09-24","current":34.598425,"twenty":15.245453,"median":29.856706,"eighty":37.827164,"marketCap":210036661290},{"date":"2021-10-01","current":34.286311,"twenty":15.245453,"median":29.856706,"eighty":37.693048,"marketCap":208141907223},{"date":"2021-10-08","current":34.935927,"twenty":15.245453,"median":29.856706,"eighty":37.668179,"marketCap":212085534108},{"date":"2021-10-15","current":35.524316,"twenty":15.245453,"median":29.856706,"eighty":37.622739,"marketCap":215657462826},{"date":"2021-10-22","current":36.400925,"twenty":15.245453,"median":29.856706,"eighty":37.545092,"marketCap":220979092668},{"date":"2021-10-29","current":38.671803,"twenty":15.245453,"median":29.856706,"eighty":37.545092,"marketCap":230963478040},{"date":"2021-11-05","current":40.226205,"twenty":15.245453,"median":29.856706,"eighty":37.622739,"marketCap":240246984145},{"date":"2021-11-12","current":39.414091,"twenty":15.245453,"median":29.856706,"eighty":37.668179,"marketCap":235396714842},{"date":"2021-11-19","current":39.573477,"twenty":15.245453,"median":29.856706,"eighty":37.693048,"marketCap":236348636855},{"date":"2021-11-26","current":39.523384,"twenty":15.245453,"median":29.856706,"eighty":37.732652,"marketCap":236049461365},{"date":"2021-12-03","current":37.278307,"twenty":15.245453,"median":29.894138,"eighty":37.820463,"marketCap":222640959872},{"date":"2021-12-10","current":37.059719,"twenty":15.245453,"median":29.916885,"eighty":37.820463,"marketCap":221335466827},{"date":"2021-12-17","current":40.593553,"twenty":15.245453,"median":29.916885,"eighty":37.863818,"marketCap":242440937736},{"date":"2021-12-23","current":41.45576,"twenty":15.245453,"median":29.916885,"eighty":37.970561,"marketCap":247590382528},{"date":"2021-12-31","current":41.929367,"twenty":15.245453,"median":29.916885,"eighty":38.066155,"marketCap":250418950794},{"date":"2022-01-07","current":39.391321,"twenty":15.251094,"median":29.928979,"eighty":38.149959,"marketCap":235260725983},{"date":"2022-01-14","current":37.056683,"twenty":15.251094,"median":29.928979,"eighty":38.205547,"marketCap":221317334979},{"date":"2022-01-21","current":36.895778,"twenty":15.251094,"median":29.928979,"eighty":38.205547,"marketCap":220356347042},{"date":"2022-01-28","current":37.205444,"twenty":15.251094,"median":29.928979,"eighty":38.205547,"marketCap":222205795524},{"date":"2022-02-04","current":39.222477,"twenty":15.251094,"median":29.928979,"eighty":38.218502,"marketCap":218928100254},{"date":"2022-02-11","current":38.165298,"twenty":15.251094,"median":29.928979,"eighty":38.233384,"marketCap":213027243793},{"date":"2022-02-18","current":38.905161,"twenty":15.251094,"median":29.928979,"eighty":38.33418,"marketCap":217156939662},{"date":"2022-02-25","current":40.552838,"twenty":15.251094,"median":29.928979,"eighty":38.439335,"marketCap":226353776557},{"date":"2022-03-04","current":42.496012,"twenty":15.251094,"median":29.928979,"eighty":38.500976,"marketCap":237199989011},{"date":"2022-03-11","current":43.050511,"twenty":15.251094,"median":29.928979,"eighty":38.673349,"marketCap":240295039653},{"date":"2022-03-18","current":46.500372,"twenty":15.251094,"median":29.928979,"eighty":38.758659,"marketCap":259551127322},{"date":"2022-03-25","current":46.723465,"twenty":15.251094,"median":29.928979,"eighty":38.841271,"marketCap":260796366356},{"date":"2022-04-01","current":47.313531,"twenty":15.251094,"median":29.928979,"eighty":38.993237,"marketCap":264089933366},{"date":"2022-04-08","current":50.388336,"twenty":15.251094,"median":29.928979,"eighty":39.135432,"marketCap":281252575702},{"date":"2022-04-14","current":48.799202,"twenty":15.251094,"median":29.928979,"eighty":39.231382,"marketCap":272382503454},{"date":"2022-04-22","current":45.059966,"twenty":15.251094,"median":29.928979,"eighty":39.342269,"marketCap":251511214429},{"date":"2022-04-29","current":42.902715,"twenty":15.251094,"median":29.928979,"eighty":39.394174,"marketCap":262963611970},{"date":"2022-05-06","current":43.603246,"twenty":15.251094,"median":29.928979,"eighty":39.442623,"marketCap":267257373067},{"date":"2022-05-13","current":42.829284,"twenty":15.251094,"median":29.928979,"eighty":39.525509,"marketCap":262513532191},{"date":"2022-05-20","current":43.889626,"twenty":15.251094,"median":29.928979,"eighty":39.567406,"marketCap":269012684207},{"date":"2022-05-27","current":47.50683,"twenty":15.251094,"median":29.928979,"eighty":39.684083,"marketCap":291183614145},{"date":"2022-06-03","current":44.300839,"twenty":15.251094,"median":29.928979,"eighty":39.75963,"marketCap":271533130972},{"date":"2022-06-10","current":43.6194,"twenty":15.251094,"median":29.928979,"eighty":39.831921,"marketCap":267356390618},{"date":"2022-06-17","current":42.722075,"twenty":15.251094,"median":29.928979,"eighty":39.99547,"marketCap":261856415713},{"date":"2022-06-24","current":47.821114,"twenty":15.245453,"median":29.916885,"eighty":40.119456,"marketCap":293109955601},{"date":"2022-07-01","current":47.68747,"twenty":15.245453,"median":29.916885,"eighty":40.231279,"marketCap":292290810402},{"date":"2022-07-08","current":48.533394,"twenty":15.245453,"median":29.916885,"eighty":40.282884,"marketCap":297475729462},{"date":"2022-07-15","current":48.699347,"twenty":15.245453,"median":29.916885,"eighty":40.411393,"marketCap":298492909764},{"date":"2022-07-22","current":48.280791,"twenty":15.245453,"median":29.916885,"eighty":40.485305,"marketCap":295927455021},{"date":"2022-07-29","current":48.418841,"twenty":15.245453,"median":29.916885,"eighty":40.547563,"marketCap":296773605006},{"date":"2022-08-05","current":50.303373,"twenty":15.245453,"median":29.916885,"eighty":40.622706,"marketCap":286306675858},{"date":"2022-08-12","current":51.43191,"twenty":15.245453,"median":29.916885,"eighty":40.962997,"marketCap":292729857621},{"date":"2022-08-19","current":53.884308,"twenty":15.245453,"median":29.916885,"eighty":41.240732,"marketCap":306687925683},{"date":"2022-08-26","current":52.680646,"twenty":15.245453,"median":29.916885,"eighty":41.859057,"marketCap":299837165252},{"date":"2022-09-02","current":50.305042,"twenty":15.245453,"median":29.916885,"eighty":42.05955,"marketCap":286316177606},{"date":"2022-09-09","current":53.037905,"twenty":15.245453,"median":29.916885,"eighty":42.276859,"marketCap":301870539360},{"date":"2022-09-16","current":51.567134,"twenty":15.245453,"median":29.916885,"eighty":42.479321,"marketCap":293499499223},{"date":"2022-09-23","current":51.996178,"twenty":15.245453,"median":29.916885,"eighty":42.744398,"marketCap":295941448502},{"date":"2022-09-30","current":53.981135,"twenty":15.245453,"median":29.916885,"eighty":42.964876,"marketCap":307239027076},{"date":"2022-10-07","current":54.533717,"twenty":15.245453,"median":29.916885,"eighty":43.406066,"marketCap":310384105721},{"date":"2022-10-14","current":55.323359,"twenty":15.245453,"median":29.916885,"eighty":43.814059,"marketCap":314878432605},{"date":"2022-10-21","current":56.889288,"twenty":15.245453,"median":29.916885,"eighty":44.425377,"marketCap":323791072389},{"date":"2022-10-28","current":60.082915,"twenty":15.245453,"median":29.916885,"eighty":44.787382,"marketCap":341967916638},{"date":"2022-11-04","current":56.289048,"twenty":15.245453,"median":29.916885,"eighty":45.700559,"marketCap":339603083239},{"date":"2022-11-11","current":55.484266,"twenty":15.245453,"median":29.916885,"eighty":46.033513,"marketCap":334747674170},{"date":"2022-11-18","current":56.959962,"twenty":15.245453,"median":29.916885,"eighty":46.096136,"marketCap":343650841093},{"date":"2022-11-25","current":57.523781,"twenty":15.245453,"median":29.916885,"eighty":46.503605,"marketCap":347052477975},{"date":"2022-12-02","current":59.021526,"twenty":15.245453,"median":29.916885,"eighty":46.820786,"marketCap":356088669804},{"date":"2022-12-09","current":56.852867,"twenty":15.245453,"median":29.916885,"eighty":47.19243,"marketCap":343004720121},{"date":"2022-12-16","current":56.676477,"twenty":15.245453,"median":29.916885,"eighty":47.35518,"marketCap":341940520873},{"date":"2022-12-23","current":57.941134,"twenty":15.245453,"median":29.916885,"eighty":47.609927,"marketCap":349570449410},{"date":"2022-12-30","current":57.616701,"twenty":15.245453,"median":29.916885,"eighty":47.946828,"marketCap":347613082936},{"date":"2023-01-06","current":57.159976,"twenty":15.245453,"median":29.916885,"eighty":48.055506,"marketCap":344857567026},{"date":"2023-01-13","current":56.952087,"twenty":15.245453,"median":29.916885,"eighty":48.352753,"marketCap":343603332198},{"date":"2023-01-20","current":54.503094,"twenty":15.245453,"median":29.916885,"eighty":48.597719,"marketCap":328828065853},{"date":"2023-01-27","current":53.877852,"twenty":15.245453,"median":29.916885,"eighty":48.85158,"marketCap":325055859590},{"date":"2023-02-03","current":51.592737,"twenty":15.325382,"median":29.992991,"eighty":49.895591,"marketCap":322186322332},{"date":"2023-02-10","current":52.511753,"twenty":15.471726,"median":30.118878,"eighty":50.310096,"marketCap":327925396848},{"date":"2023-02-17","current":49.967721,"twenty":15.626479,"median":30.243653,"eighty":50.433148,"marketCap":312038422360},{"date":"2023-02-24","current":46.452439,"twenty":15.778144,"median":30.341363,"eighty":50.433148,"marketCap":290086191606},{"date":"2023-03-03","current":45.988839,"twenty":15.854595,"median":30.51895,"eighty":50.433148,"marketCap":287191101832},{"date":"2023-03-10","current":45.496354,"twenty":15.907334,"median":32.742097,"eighty":50.433148,"marketCap":284115632632},{"date":"2023-03-17","current":47.541394,"twenty":15.945272,"median":33.093107,"eighty":50.433148,"marketCap":296886495936},{"date":"2023-03-24","current":48.545139,"twenty":15.990139,"median":33.435127,"eighty":50.433148,"marketCap":303154680962},{"date":"2023-03-31","current":49.597987,"twenty":16.097458,"median":33.751835,"eighty":50.410742,"marketCap":309729511010},{"date":"2023-04-06","current":52.316041,"twenty":16.2755,"median":34.072503,"eighty":50.694658,"marketCap":326703214922},{"date":"2023-04-13","current":53.299567,"twenty":16.395447,"median":34.265808,"eighty":51.019152,"marketCap":332845134350},{"date":"2023-04-21","current":54.131447,"twenty":16.469273,"median":34.485523,"eighty":51.319724,"marketCap":338040061796},{"date":"2023-04-28","current":61.907495,"twenty":16.478563,"median":34.486423,"eighty":51.368358,"marketCap":352055543134},{"date":"2023-05-05","current":71.517637,"twenty":16.478563,"median":34.486423,"eighty":51.368358,"marketCap":406706495414},{"date":"2023-05-12","current":72.704478,"twenty":16.478563,"median":34.486423,"eighty":51.368358,"marketCap":413455825968},{"date":"2023-05-19","current":73.095084,"twenty":16.478563,"median":34.486423,"eighty":51.368358,"marketCap":415677124631},{"date":"2023-05-26","current":71.329011,"twenty":16.477036,"median":34.485973,"eighty":51.335083,"marketCap":405633817000},{"date":"2023-06-02","current":72.861388,"twenty":16.477036,"median":34.485973,"eighty":51.335083,"marketCap":414348142525},{"date":"2023-06-09","current":74.392097,"twenty":16.477036,"median":34.485973,"eighty":51.335083,"marketCap":423052975320},{"date":"2023-06-16","current":75.772572,"twenty":16.477036,"median":34.485973,"eighty":51.335083,"marketCap":430903462476},{"date":"2023-06-23","current":76.398543,"twenty":16.475095,"median":34.485523,"eighty":51.273648,"marketCap":434463235975},{"date":"2023-06-30","current":77.535307,"twenty":16.473154,"median":34.443411,"eighty":51.236252,"marketCap":440927784649},{"date":"2023-07-07","current":77.321642,"twenty":16.473154,"median":34.443411,"eighty":51.236252,"marketCap":439712715294},{"date":"2023-07-14","current":72.562591,"twenty":16.473154,"median":34.443411,"eighty":51.236252,"marketCap":412648943975},{"date":"2023-07-21","current":77.423467,"twenty":16.473154,"median":34.443411,"eighty":51.236252,"marketCap":440291771784},{"date":"2023-07-28","current":75.949513,"twenty":16.561055,"median":34.520298,"eighty":51.486,"marketCap":431909691785},{"date":"2023-08-04","current":74.976337,"twenty":16.648676,"median":34.604947,"eighty":51.685351,"marketCap":426375430586},{"date":"2023-08-11","current":72.15676,"twenty":16.778484,"median":34.761377,"eighty":51.913041,"marketCap":468838545491},{"date":"2023-08-18","current":74.415551,"twenty":16.829645,"median":34.900087,"eighty":52.353704,"marketCap":483515042715},{"date":"2023-08-25","current":75.846673,"twenty":16.873693,"median":35.027681,"eighty":52.642583,"marketCap":492813754804},{"date":"2023-09-01","current":76.704792,"twenty":16.943276,"median":35.199465,"eighty":52.935996,"marketCap":498389384876},{"date":"2023-09-08","current":79.338664,"twenty":16.995723,"median":35.327937,"eighty":53.305793,"marketCap":515502972018},{"date":"2023-09-15","current":81.882573,"twenty":17.014221,"median":35.518939,"eighty":53.718848,"marketCap":532032017298},{"date":"2023-09-22","current":76.141478,"twenty":17.045869,"median":35.803576,"eighty":53.94207,"marketCap":494729253522},{"date":"2023-09-29","current":75.35533,"twenty":17.081428,"median":36.024425,"eighty":54.124515,"marketCap":489621256939},{"date":"2023-10-06","current":74.944263,"twenty":17.109303,"median":36.337145,"eighty":54.515343,"marketCap":486950350276},{"date":"2023-10-13","current":84.497069,"twenty":17.184663,"median":36.461597,"eighty":54.950742,"marketCap":549019703116},{"date":"2023-10-20","current":81.769735,"twenty":17.217338,"median":36.786995,"eighty":55.102822,"marketCap":531298853537},{"date":"2023-10-27","current":78.627939,"twenty":17.419573,"median":36.895778,"eighty":55.323359,"marketCap":510885035027},{"date":"2023-11-03","current":104.612169,"twenty":21.308556,"median":37.087043,"eighty":55.484266,"marketCap":521847345496},{"date":"2023-11-10","current":106.60299,"twenty":21.362242,"median":37.197854,"eighty":55.528364,"marketCap":531778355382},{"date":"2023-11-17","current":106.139671,"twenty":21.351505,"median":37.142449,"eighty":55.493086,"marketCap":529467135783},{"date":"2023-11-24","current":108.366125,"twenty":21.340768,"median":37.087043,"eighty":55.45884,"marketCap":540573580160},{"date":"2023-12-01","current":106.552512,"twenty":21.340768,"median":37.087043,"eighty":55.45884,"marketCap":531526549356},{"date":"2023-12-08","current":106.053137,"twenty":21.340768,"median":37.087043,"eighty":55.45884,"marketCap":529035468309},{"date":"2023-12-15","current":103.421053,"twenty":21.340768,"median":37.087043,"eighty":55.45884,"marketCap":515905582649},{"date":"2023-12-22","current":103.119986,"twenty":21.33003,"median":37.073381,"eighty":55.440571,"marketCap":514403739564},{"date":"2023-12-29","current":104.715462,"twenty":21.319293,"median":37.059719,"eighty":55.428569,"marketCap":522362608611},{"date":"2024-01-05","current":110.781873,"twenty":21.308556,"median":37.058201,"eighty":55.388467,"marketCap":552624297136},{"date":"2024-01-12","current":114.607409,"twenty":21.308556,"median":37.058201,"eighty":55.388467,"marketCap":571707596705},{"date":"2024-01-19","current":112.377349,"twenty":21.291637,"median":37.056683,"eighty":55.369554,"marketCap":560583166183},{"date":"2024-01-26","current":113.147143,"twenty":21.308556,"median":37.058201,"eighty":55.388467,"marketCap":564423208085},{"date":"2024-02-02","current":119.06212,"twenty":21.308556,"median":37.058201,"eighty":55.388467,"marketCap":593929478531},{"date":"2024-02-09","current":126.250353,"twenty":21.308556,"median":37.073381,"eighty":55.484266,"marketCap":661602348116},{"date":"2024-02-16","current":130.042943,"twenty":21.308556,"median":37.142449,"eighty":55.583486,"marketCap":681477038053},{"date":"2024-02-23","current":132.204139,"twenty":21.308556,"median":37.142449,"eighty":55.903194,"marketCap":692802568837},{"date":"2024-03-01","current":129.462626,"twenty":21.319293,"median":37.197854,"eighty":56.34606,"marketCap":678435944183},{"date":"2024-03-08","current":134.011201,"twenty":21.319293,"median":37.197854,"eighty":56.669232,"marketCap":702272298872},{"date":"2024-03-15","current":130.673632,"twenty":21.319293,"median":37.197854,"eighty":56.849402,"marketCap":684782103569},{"date":"2024-03-22","current":132.310639,"twenty":21.319293,"median":37.197854,"eighty":56.961222,"marketCap":693360670797},{"date":"2024-03-28","current":133.760431,"twenty":21.319293,"median":37.197854,"eighty":57.206593,"marketCap":700958163698},{"date":"2024-04-05","current":132.024354,"twenty":21.308556,"median":37.142449,"eighty":57.495433,"marketCap":691860426088},{"date":"2024-04-12","current":130.565018,"twenty":21.308556,"median":37.142449,"eighty":57.616701,"marketCap":684212921899},{"date":"2024-04-19","current":128.220455,"twenty":21.308556,"median":37.263886,"eighty":57.958458,"marketCap":671926472295},{"date":"2024-04-26","current":124.597039,"twenty":21.319293,"median":37.62744,"eighty":58.29108,"marketCap":652938322907},{"date":"2024-05-03","current":110.879942,"twenty":21.47727,"median":37.84451,"eighty":58.946995,"marketCap":680625435331},{"date":"2024-05-10","current":113.17408,"twenty":22.864826,"median":37.995307,"eighty":61.6157,"marketCap":694707775568},{"date":"2024-05-17","current":113.111006,"twenty":23.063427,"median":38.439376,"eighty":70.063714,"marketCap":694320601252},{"date":"2024-05-24","current":118.586722,"twenty":23.228414,"median":38.682429,"eighty":71.395781,"marketCap":727932734311},{"date":"2024-05-31","current":119.556304,"twenty":23.350464,"median":38.790319,"eighty":71.918926,"marketCap":733884413913},{"date":"2024-06-07","current":122.81709,"twenty":23.554918,"median":38.989059,"eighty":72.528204,"marketCap":753900425643},{"date":"2024-06-14","current":129.570424,"twenty":23.602801,"median":39.184569,"eighty":72.766241,"marketCap":795355089615},{"date":"2024-06-21","current":129.960603,"twenty":23.67921,"median":39.296727,"eighty":72.915472,"marketCap":797750167942},{"date":"2024-06-28","current":133.341671,"twenty":23.787075,"median":39.374944,"eighty":73.112857,"marketCap":818504512089},{"date":"2024-07-05","current":131.736947,"twenty":23.894379,"median":39.421898,"eighty":73.780474,"marketCap":808654077166},{"date":"2024-07-12","current":137.023441,"twenty":23.991133,"median":39.480285,"eighty":74.382117,"marketCap":841104687278},{"date":"2024-07-15","current":139.115155,"twenty":24.015067,"median":39.50365,"eighty":74.400109,"marketCap":853944468082},{"date":"2024-08-02","current":122.105672,"twenty":24.163214,"median":39.66911,"eighty":74.478664,"marketCap":749533459521},{"date":"2024-08-09","current":103.666328,"twenty":24.216107,"median":39.819389,"eighty":74.957093,"marketCap":761138914401},{"date":"2024-08-16","current":114.246227,"twenty":24.283953,"median":40.100005,"eighty":75.390022,"marketCap":838818646269},{"date":"2024-08-23","current":117.016598,"twenty":24.408112,"median":40.312064,"eighty":75.622149,"marketCap":859159264594},{"date":"2024-08-30","current":115.303358,"twenty":24.49169,"median":40.4539,"eighty":75.712813,"marketCap":846580316475},{"date":"2024-09-06","current":111.936971,"twenty":24.641744,"median":40.593553,"eighty":75.853756,"marketCap":821863628869},{"date":"2024-09-13","current":114.668098,"twenty":24.686059,"median":41.45576,"eighty":76.127084,"marketCap":841916110945},{"date":"2024-09-20","current":112.21781,"twenty":24.765221,"median":41.961244,"eighty":76.384522,"marketCap":823925603901},{"date":"2024-09-27","current":111.516326,"twenty":24.962812,"median":42.261802,"eighty":76.589989,"marketCap":818775168450},{"date":"2024-10-04","current":108.601243,"twenty":25.074864,"median":42.357434,"eighty":76.666318,"marketCap":797372047707},{"date":"2024-10-11","current":111.684339,"twenty":25.269358,"median":42.70592,"eighty":77.022845,"marketCap":820008751766},{"date":"2024-10-18","current":112.472895,"twenty":25.681877,"median":42.902715,"eighty":77.362372,"marketCap":825798489519},{"date":"2024-10-25","current":109.308859,"twenty":25.853979,"median":43.309522,"eighty":77.934384,"marketCap":802567504446},{"date":"2024-10-31","current":90.988842,"twenty":25.962098,"median":43.6194,"eighty":78.93258,"marketCap":761567509150},{"date":"2024-11-08","current":85.683138,"twenty":26.195803,"median":44.282481,"eighty":79.978102,"marketCap":717159300180},{"date":"2024-11-15","current":84.582455,"twenty":26.330032,"median":44.543895,"eighty":82.210596,"marketCap":707946685954},{"date":"2024-11-22","current":80.676233,"twenty":26.519078,"median":44.994283,"eighty":82.210596,"marketCap":675251998436},{"date":"2024-11-29","current":85.563582,"twenty":26.676342,"median":45.255888,"eighty":82.923666,"marketCap":716158626195},{"date":"2024-12-06","current":88.820022,"twenty":26.753791,"median":45.725105,"eighty":84.267868,"marketCap":743414704167},{"date":"2024-12-13","current":84.165045,"twenty":26.822269,"median":45.965739,"eighty":85.17408,"marketCap":704453009623},{"date":"2024-12-20","current":81.49599,"twenty":26.880469,"median":46.071101,"eighty":85.17408,"marketCap":682113290611},{"date":"2024-12-27","current":85.433411,"twenty":26.945486,"median":46.130976,"eighty":85.563582,"marketCap":715069103422},{"date":"2025-01-03","current":83.704603,"twenty":27.014133,"median":46.504413,"eighty":85.563582,"marketCap":700599160475},{"date":"2025-01-10","current":84.688958,"twenty":27.076516,"median":46.818846,"eighty":85.563582,"marketCap":708838113677},{"date":"2025-01-17","current":81.502445,"twenty":27.115129,"median":47.111453,"eighty":85.598008,"marketCap":682167316534},{"date":"2025-01-24","current":82.470663,"twenty":27.184274,"median":47.284431,"eighty":85.598008,"marketCap":690271204930},{"date":"2025-01-31","current":88.562907,"twenty":27.226987,"median":47.357031,"eighty":85.973461,"marketCap":741262671582},{"date":"2025-02-07","current":74.004631,"twenty":27.291918,"median":47.541394,"eighty":86.491996,"marketCap":783709038136},{"date":"2025-02-14","current":74.13132,"twenty":27.393617,"median":47.68747,"eighty":86.491996,"marketCap":785050681881},{"date":"2025-02-21","current":74.051954,"twenty":27.469575,"median":47.906294,"eighty":86.491996,"marketCap":784210189526},{"date":"2025-02-28","current":76.769363,"twenty":27.750068,"median":48.050219,"eighty":86.491996,"marketCap":812987556294},{"date":"2025-03-07","current":77.413942,"twenty":27.999171,"median":48.308222,"eighty":86.502754,"marketCap":819813648287},{"date":"2025-03-14","current":67.990366,"twenty":28.826215,"median":48.520491,"eighty":86.502754,"marketCap":720017979698},{"date":"2025-03-21","current":71.460916,"twenty":29.057481,"median":48.692738,"eighty":86.502754,"marketCap":756771096057},{"date":"2025-03-28","current":69.674291,"twenty":29.173861,"median":49.06693,"eighty":86.502754,"marketCap":737850745702},{"date":"2025-04-04","current":66.911639,"twenty":29.468797,"median":49.605593,"eighty":86.502754,"marketCap":708594259162},{"date":"2025-04-11","current":61.130251,"twenty":29.547726,"median":49.947,"eighty":86.491996,"marketCap":647369358847},{"date":"2025-04-17","current":62.316546,"twenty":29.70028,"median":50.303373,"eighty":86.491996,"marketCap":659932227069},{"date":"2025-04-25","current":72.901625,"twenty":29.802009,"median":50.543771,"eighty":86.502754,"marketCap":772028212789},{"date":"2025-05-02","current":64.187485,"twenty":29.988514,"median":51.011538,"eighty":86.502754,"marketCap":712891880459},{"date":"2025-05-09","current":60.740065,"twenty":30.117414,"median":51.296686,"eighty":86.502754,"marketCap":674603454943},{"date":"2025-05-16","current":59.272183,"twenty":30.230011,"median":51.599969,"eighty":86.502754,"marketCap":658300575521},{"date":"2025-05-23","current":57.80996,"twenty":30.341363,"median":51.790838,"eighty":86.502754,"marketCap":642060537595},{"date":"2025-05-30","current":58.40568,"twenty":30.440896,"median":51.966128,"eighty":86.502754,"marketCap":648676849343},{"date":"2025-06-06","current":61.890282,"twenty":32.608537,"median":52.460976,"eighty":86.502754,"marketCap":687378233257},{"date":"2025-06-13","current":65.636775,"twenty":33.039737,"median":52.675638,"eighty":86.502754,"marketCap":728988280681},{"date":"2025-06-20","current":63.454352,"twenty":33.324716,"median":53.003498,"eighty":86.522333,"marketCap":704749418104},{"date":"2025-06-27","current":64.269932,"twenty":33.732043,"median":53.423771,"eighty":86.522333,"marketCap":713807570823},{"date":"2025-07-03","current":63.101931,"twenty":34.046365,"median":53.776165,"eighty":86.522333,"marketCap":700835290666},{"date":"2025-07-11","current":63.90862,"twenty":34.27811,"median":53.946077,"eighty":86.522333,"marketCap":709794692463}],"updateTime":1752484823533}}}